Karolinska Development

1,608SEK +2,29 %
1 investor følger denne virksomhed

Karolinska Development is a Nordic investment company in the life science sector. The company focuses on identifying medical innovations to create and develop companies that further develop such innovations into differentiated products. Karolinska Development's portfolio consists of a number of companies focused on developing treatment methods for diseases that are classified as life-threatening and serious. The largest business operations are in the Nordic market.

Omsætning
2,3 mio.
EBIT %
-3.800,87 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
KDEV
Daglig lav / høj pris
1,564 / 1,608 SEK
Markedsværdi
280,05 mio. SEK
Aktieomsætning
147,82 t SEK
Volumen
93 t

Finanskalender

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
invoX Pharma Ltd47,7 %43,9 %
Worldwide International Investments Ltd10,4 %9,6 %
Premium
Not activated

This content is for our Premium customers only.